QuantiFERON-TB Gold conversion is not uncommon in patients with psoriasis undergoing anti-tumour necrosis factor-α therapy.

Authors	M Megna, A Ruggiero, M Ferrillo, G Fabbrocini
Journal	The British journal of dermatology (Br J Dermatol) Vol. 183 Issue 5 Pg. 977-978 (11 2020) ISSN: 1365-2133 [Electronic] England
PMID	32531802 (Publication Type: Letter)
Chemical References	Tumor Necrosis Factor-alpha
Topics	Humans Interferon-gamma Release Tests Latent Tuberculosis (diagnosis, drug therapy) Psoriasis (drug therapy) Tuberculin Test Tumor Necrosis Factor-alpha

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!